Forty Seven, Inc.

/Forty Seven, Inc.

IPO

Forty Seven, Inc.

We are a clinical-stage immuno-oncology company focused on developing novel checkpoint therapies to activate macrophages in the fight against cancer.

Symbol

FTSV

Price Range
$14.00 - $16.00

Final Shares
6,700,000

Anticipated Date
TBD

Underwriters
MORGAN STANLEY, CREDIT SUISSE, CANACCORD GENUITY, BTIG, OPPENHEIMER & CO.

To view the prospectus for Forty Seven, Inc. IPO, or any offering listed on ClickIPO,
download the ClickIPO app...

or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC P. O. Box 21154, Mesa, AZ 85277